PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,211,000 | +32.1% | 169,781 | +342.0% | 0.03% | +94.1% |
| Q4 2019 | $917,000 | +320.6% | 38,410 | +373.0% | 0.02% | +325.0% |
| Q3 2019 | $218,000 | -86.0% | 8,120 | -85.8% | 0.00% | -86.2% |
| Q2 2019 | $1,557,000 | +391.2% | 57,373 | +382.0% | 0.03% | +70.6% |
| Q3 2018 | $317,000 | -34.5% | 11,903 | -7.1% | 0.02% | -29.2% |
| Q2 2018 | $484,000 | +122.0% | 12,806 | +217.1% | 0.02% | +100.0% |
| Q3 2017 | $218,000 | -77.2% | 4,039 | -91.4% | 0.01% | -78.2% |
| Q1 2016 | $956,000 | +17.7% | 46,878 | +197.2% | 0.06% | +14.6% |
| Q4 2015 | $812,000 | +128.1% | 15,773 | +101.9% | 0.05% | +182.4% |
| Q2 2015 | $356,000 | -27.9% | 7,813 | -40.0% | 0.02% | -29.2% |
| Q1 2015 | $494,000 | – | 13,023 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 170,129 | $3,321,000 | 9.18% |
| CADIAN CAPITAL MANAGEMENT, LP | 6,462,605 | $126,150,000 | 5.87% |
| Fernwood Investment Management, LLC | 340,263 | $6,642,000 | 4.28% |
| Tamarack Advisers, LP | 400,000 | $7,808,000 | 3.18% |
| Grace Capital | 279,209 | $5,456,000 | 2.53% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,582,129 | $30,883,000 | 2.37% |
| Foresite Capital Management IV, LLC | 250,000 | $4,880,000 | 2.24% |
| SECTORAL ASSET MANAGEMENT INC | 823,607 | $16,077,000 | 2.18% |
| HARVEY CAPITAL MANAGEMENT INC | 164,672 | $3,214,000 | 1.71% |
| WISCONSIN CAPITAL MANAGEMENT LLC | 68,549 | $1,338,000 | 1.42% |